+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Johnson & Johnson Services, Inc. - logo

Johnson & Johnson has more than 250 companies located in 60 countries around the world. Their companies are broken down into several business segments: consumer healthcare, medical devices and pharmaceuticals. Johnson & Johnson’s consumer healthcare segment produces a variety of consumer care products in the areas of baby care, skin and hair care, wound care, oral health, OTC medicines and nutritionals. Their medical devices segment produces a broad range of products used by healthcare professionals in the fields of orthopaedics, neurovascular, surgery, vision care, diabetes care, infection prevention, cardiovascular disease, sports medicine, and aesthetics. The Janssen Pharmaceutical Companies of Johnson & Johnson are focused on oncology, immunology, neuroscience and infectious diseases, as well as cardiovascular and metabolic diseases. Their company headquarters are based in New Brunswick, New Jersey, USA.

US Wound Care Market - Focused Insights 2023-2028 - Product Thumbnail Image

US Wound Care Market - Focused Insights 2023-2028

  • Report
  • July 2023
  • 78 Pages
  • United States
From
Hydrogel Market 2024-2028 - Product Thumbnail Image

Hydrogel Market 2024-2028

  • Report
  • January 2024
  • 165 Pages
  • Global
From
Cancer Biologics Market - Global Forecast 2025-2030 - Product Thumbnail Image

Cancer Biologics Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 187 Pages
  • Global
From
Spinal Devices & Biologics Market - Global Forecast 2025-2030 - Product Thumbnail Image

Spinal Devices & Biologics Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 183 Pages
  • Global
From
Antidiarrheals Market Report 2025 - Product Thumbnail Image

Antidiarrheals Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
Immunotherapy Drugs - Global Strategic Business Report - Product Thumbnail Image

Immunotherapy Drugs - Global Strategic Business Report

  • Report
  • September 2025
  • 193 Pages
  • Global
From
From
Cancer Antibody Drug Conjugates - Global Strategic Business Report - Product Thumbnail Image

Cancer Antibody Drug Conjugates - Global Strategic Business Report

  • Report
  • September 2025
  • 482 Pages
  • Global
From
Angiosarcoma Treatment - Global Strategic Business Report - Product Thumbnail Image

Angiosarcoma Treatment - Global Strategic Business Report

  • Report
  • September 2025
  • 390 Pages
  • Global
From
Ewing Sarcoma - Global Strategic Business Report - Product Thumbnail Image

Ewing Sarcoma - Global Strategic Business Report

  • Report
  • September 2025
  • 377 Pages
  • Global
From
Antineoplastic Agents - Global Strategic Business Report - Product Thumbnail Image

Antineoplastic Agents - Global Strategic Business Report

  • Report
  • September 2025
  • 183 Pages
  • Global
From
Cancer Immunotherapy - Global Strategic Business Report - Product Thumbnail Image

Cancer Immunotherapy - Global Strategic Business Report

  • Report
  • September 2025
  • 291 Pages
  • Global
From
Sarcoma Drugs - Global Strategic Business Report - Product Thumbnail Image

Sarcoma Drugs - Global Strategic Business Report

  • Report
  • September 2025
  • 126 Pages
  • Global
From
Blood Cancer Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Blood Cancer Therapeutics - Global Strategic Business Report

  • Report
  • September 2025
  • 291 Pages
  • Global
From
Epithelioma Treatment - Global Strategic Business Report - Product Thumbnail Image

Epithelioma Treatment - Global Strategic Business Report

  • Report
  • September 2025
  • 380 Pages
  • Global
From
From
Retinoblastoma Treatment - Global Strategic Business Report - Product Thumbnail Image

Retinoblastoma Treatment - Global Strategic Business Report

  • Report
  • September 2025
  • 279 Pages
  • Global
From
Metastatic Cancer Drugs - Global Strategic Business Report - Product Thumbnail Image

Metastatic Cancer Drugs - Global Strategic Business Report

  • Report
  • September 2025
  • 377 Pages
  • Global
From
Bortezomib - Global Strategic Business Report - Product Thumbnail Image

Bortezomib - Global Strategic Business Report

  • Report
  • September 2025
  • 377 Pages
  • Global
From
Loading Indicator